Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) FCF Margin: 2020-2025

Historic FCF Margin for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to 8.22%.

  • GeneDx Holdings' FCF Margin rose 1500.00% to 8.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.89%, marking a year-over-year increase of 2640.00%. This contributed to the annual value of -11.13% for FY2024, which is 8040.00% up from last year.
  • As of Q3 2025, GeneDx Holdings' FCF Margin stood at 8.22%, which was up 4.83% from 7.84% recorded in Q2 2025.
  • GeneDx Holdings' FCF Margin's 5-year high stood at 8.22% during Q3 2025, with a 5-year trough of -239.34% in Q2 2022.
  • Over the past 3 years, GeneDx Holdings' median FCF Margin value was -8.31% (recorded in 2024), while the average stood at -36.91%.
  • Its FCF Margin has fluctuated over the past 5 years, first slumped by 17,865bps in 2022, then surged by 12,603bps in 2023.
  • GeneDx Holdings' FCF Margin (Quarterly) stood at -94.50% in 2021, then slumped by 1,198bps to -106.48% in 2022, then skyrocketed by 5,034bps to -56.14% in 2023, then surged by 4,980bps to -6.34% in 2024, then surged by 1,500bps to 8.22% in 2025.
  • Its last three reported values are 8.22% in Q3 2025, 7.84% for Q2 2025, and 4.65% during Q1 2025.